AIM ImmunoTech

AIM ImmunoTech Current Liabilities

The Current Liabilities of AIM ImmunoTech (AIM) as of Oct 12, 2026 is 6.22 M USD. In the previous year, Current Liabilities was 12.69 M USD — a change of -50.94% (lower).

Current Liabilities

6.22 MUSD

YoY

-50.94%

Last updated:

Current Liabilities of AIM ImmunoTech is 2025 6.22 M USD. Current Liabilities of AIM ImmunoTech was 2024 12.69 M USD. It decreases by -50.94% lower compared to the previous year.

The AIM ImmunoTech Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
6.50 M USD
Jan 1, 2019
1.78 M USD
Jan 1, 2020
1.82 M USD
Jan 1, 2021
1.15 M USD
Jan 1, 2022
2.34 M USD
Jan 1, 2023
10.86 M USD
Jan 1, 2024
12.69 M USD
Jan 1, 2025
6.22 M USD
The AIM ImmunoTech Current Liabilities history
YEARCurrent LiabilitiesYoY
6.22 MUSD-50.94%
12.69 MUSD+16.81%
10.86 MUSD+363.16%
2.34 MUSD+104.27%
1.15 MUSD-36.96%
1.82 MUSD+2.19%
1.78 MUSD-72.57%
6.50 MUSD+39.01%
4.67 MUSD+17.32%
3.98 MUSD+9.03%
3.65 MUSD-46.03%
6.77 MUSD+78.51%
3.79 MUSD-76.27%
15.98 MUSD+140.32%
6.65 MUSD+57.48%
4.22 MUSD+10.38%
3.83 MUSD+58.91%
2.41 MUSD-18.87%
2.97 MUSD-74.88%
11.81 MUSD+333.24%
2.73 MUSD-69.87%
9.05 MUSD+231.72%
2.73 MUSD+27.19%
2.14 MUSD+37.26%
1.56 MUSD-5.05%
1.64 MUSD-11.56%
1.86 MUSD+37.78%
1.35 MUSD+27.36%
1.06 MUSD-23.74%
1.39 MUSD-86.20%
10.07 MUSD-22.78%
13.04 MUSD—
Access this data via the Eulerpool API
Get Free API Key

AIM ImmunoTech Stock analysis

What does AIM ImmunoTech do? AIM ImmunoTech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AIM ImmunoTech stock

Current Liabilities of AIM ImmunoTech is 6.22 M USD in 2025.

Current Liabilities of AIM ImmunoTech changed from 12.69 M USD to 6.22 M USD, representing a -50.94% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities AIM ImmunoTech since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's AIM ImmunoTech historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — AIM ImmunoTech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — AIM ImmunoTech